文献速递慢性静脉疾病

CEAP与Kistner分级指导深静脉干预选择:双中心队列研究

CEAP-guided and Kistner-refined selection of deep venous intervention for primary lower-limb venous valvular incompetence: A two-center cohort study.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-08-24

该双中心回顾性队列研究纳入578条原发性下肢静脉瓣膜功能不全患肢,评估CEAP临床分级与Kistner分级能否指导深静脉干预选择。结果显示联合治疗在C4-C6人群尤其Kistner 3-4级反流者中VCSS改善更优,但在C3组无额外获益。

要点

  • C3期患者联合治疗较单纯浅静脉治疗无额外VCSS获益。
  • C4-C6期患者联合治疗VCSS改善优于单纯浅静脉治疗。
  • C4-C6伴Kistner 3-4级孤立深反流者联合治疗获益最大。

核心结论

  • 选择性股静脉瓣膜成形术联合浅静脉治疗在C4-C6病变尤其Kistner 3-4级反流者中可能临床合理,但在C3病变中不支持。

研究设计与样本

  • 双中心回顾性队列研究,纳入2015至2025年间578条连续符合条件的原发性下肢静脉瓣膜功能不全患肢,均有静脉造影和临床记录。
  • 分为四组:保守治疗241条、仅浅静脉治疗240条、仅深静脉治疗44条、联合治疗53条。

关键数值与推荐

  • 深静脉干预主要为股静脉瓣膜成形术;联合治疗为股静脉瓣膜成形术加浅静脉治疗,后者多为射频消融,必要时行高位结扎剥脱。
  • 主要结局为静脉临床严重程度评分(VCSS)改善。

临床怎么用

  • 对C4-C6期原发性下肢静脉瓣膜功能不全尤其Kistner 3-4级反流者,可考虑股静脉瓣膜成形术联合浅静脉治疗。
  • C3期患者不推荐常规联合深静脉干预。

局限性

  • 回顾性队列设计可能存在选择偏倚。
  • 仅纳入有静脉造影和临床记录者,样本代表性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether the Clinical-Etiological-Anatomical-Pathophysiological (CEAP) clinical class and Kistner grade could guide the selection of deep venous intervention for primary lower-limb venous valvular incompetence. METHODS: A two-center retrospective cohort study of 578 consecutive eligible limbs with primary lower-limb venous valvular incompetence and available venographic and clinical records between 2015 and 2025 categorized into the following four groups was conducted: conservative management (n = 241), superficial-only treatment (n = 240), deep-only treatment (n = 44), and combined treatment (n = 53). Deep intervention mainly consisted of femoral vein valvuloplasty; combined treatment comprised femoral valvuloplasty plus superficial treatment, most often radiofrequency ablation, with high ligation and stripping performed when indicated. The primary outcome was Venous Clinical Severity Score (VCSS) improvement. Analyses were conducted across several populations: hierarchically in the C3 group, the overall C4-C6 population, the C4-C6 Kistner grade 3-4 isolated deep reflux subgroup, and an all-CEAP Kistner grade 3-4 sensitivity population. RESULTS: In the C3 group, combined treatment provided no additional VCSS benefit compared with superficial venous-only treatment (adjusted β, .1; 95% CI, -1.6 to 1.9; P = .872). However, in the C4-C6 population, combined treatment achieved greater VCSS improvement than superficial venous-only treatment (adjusted β, 1.8; 95% CI, 0.5-3.1; P = .007). In C4-C6 limbs with Kistner grade 3-4 isolated deep venous reflux, combined treatment showed greater benefit than both superficial venous-only treatment (adjusted β, 3.9; 95% CI, 1.1-6.6; P = .008) and conservative management (adjusted β, 4.2; 95% CI, 1.3-7.0; P = .005). All CEAP Kistner grade 3-4 sensitivity analyses showed directionally consistent results. CONCLUSIONS: Selective femoral vein valvuloplasty combined with superficial venous treatment may be clinically justified in C4-C6 disease, especially with Kistner grades 3-4 reflux; however, it is not supported in C3 disease.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Zhang B, Zhu J, Wang S, et al. CEAP-guided and Kistner-refined selection of deep venous intervention for primary lower-limb venous valvular incompetence: A two-center cohort study. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42637073. doi:10.1016/j.jvsv.2026.102604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。